The authors and their affiliations are listed, including those from Vividion Therapeutics in San Diego and collaborators from multiple other institutions such as Roche and Vall d'Hebron Institute of Oncology.
Correspondence for the article should be directed to Matthew P. Patricelli or Todd M. Kinsella, highlighting their roles as corresponding authors for this study.
[
Collection
]
[
|
...
]